TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval
TG Therapeutics shares made new 52-week highs this week, helped in part by new Briumvi data presentations at ECTRIMS. Find ...
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
CCHR Int1d
New Study Warns of High Dose “ADHD” Drugs Inducing Psychosis
CCHR has documented psychosis and violent behavior linked to any dose of the drugs and wants them prohibited as a treatment for the 3.1 million American children put at risk by taking them. By CCHR ...
US FDA approves Zevra's treatment for rare genetic disease
The company has been trying for years to bring the drug to market after the U.S. health regulator previously declined to ...
Sanofi wins US approval for multiple myeloma drug in newly diagnosed patients
Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...
STAT2d
FDA approves first drug for rare neuron disease, Niemann-Pick type C
Parents pushed for years for treatments for the neuron disease Niemann-Pick type C. After setbacks, one drug now has FDA ...
Medscape3d
Triptans Trump Newer, More Expensive Meds for Acute Migraine
The comparative efficacy and tolerability of oral migraine medications suggest four triptans are superior to the newer, more ...
Science Media Centre3d
expert reaction to network meta-analysis of medicines for migraine
‘Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis’ by William K Karlsson et al. was published in The BMJ ...
BMJ4d
Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis
The primary outcomes were the proportion of participants who were pain-free at two hours post-dose and the proportion of ...